This program addressed the unique cardiovascular (CV) risks and challenges that patients face when recovering from COVID-19, with a particular focus on thrombotic illnesses. The epidemiology, pathophysiology, and prevention of CV complications in COVID-19 were discussed, and the program concluded with a case series exploring key clinical dilemmas in COVID-19-associated thrombosis.

AGENDA:

A Public Health Challenge: The Burden of Venous and Arterial Thrombosis in COVID-19
Samuel Z. Goldhaber, MD
 
Mechanisms and Histopathology of Thrombosis in COVID-19
Galit Frydman, DVM, ScD
 
Recognizing the Hazard of Cardiovascular Complications in COVID-19
Gregory Piazza, MD, MS
 
Prevention of Thrombosis in COVID-19: Navigating the Trials and Guidance Documents
Alex Spyropoulos, MD
 
Cases: Clinical Dilemmas in Patients with COVID-19 and Thrombosis
Behnood Bikdeli, MD, MS